Complete atrioventricular block induced by rituximab in monotherapy in an aged patient with non-Hodgkin's diffuse large B-cell lymphoma.
Clin Transl Oncol
; 10(5): 298-9, 2008 May.
Article
em En
| MEDLINE
| ID: mdl-18490248
ABSTRACT
Rituximab is a treatment option to non-Hodg kin's diffuse large B-cell lymphoma (NHDLBCL) in advanced stage and comorbility. It is known the cardiotoxicity effect of this drug, but there is no previous report describing a complete atrioventricular block (CAVB) secundary to treatment with Rituximab. We present an elderly woman treated with monotherapy with Rituximab who experienced a CAVB after administration of the fifth dose of this drug.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Linfoma Difuso de Grandes Células B
/
Bloqueio Atrioventricular
/
Anticorpos Monoclonais
/
Antineoplásicos
Limite:
Aged80
/
Female
/
Humans
Idioma:
En
Revista:
Clin Transl Oncol
Ano de publicação:
2008
Tipo de documento:
Article
País de afiliação:
Espanha
País de publicação:
IT
/
ITALIA
/
ITALY
/
ITÁLIA